Ring substituent effects on biological activity of vinyl sulfones as inhibitors of HIV-1

被引:114
|
作者
Meadows, D. Christopher
Sanchez, Tino
Neamati, Nouri
North, Thomas W.
Gervay-Hague, Jacquelyn
机构
[1] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA
[2] Univ So Calif, Sch Pharm, Dept Pharmaceut Sci, Los Angeles, CA 90089 USA
[3] Univ Calif Davis, Sch Vet Med, Ctr Comparat Med, Davis, CA 95616 USA
[4] Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA
关键词
HIV-1; HIV integrase; vinyl sulfones;
D O I
10.1016/j.bmc.2006.10.017
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In a previous study, we prepared a small library of chicoric acid analogs that possessed both potent anti-integrase and antiviral activity. It was also shown that active compounds fell into one of two groups: those that inhibited an early stage in viral replication and those that inhibited at a later stage. In this study, a series of vinyl geminal disulfone-containing compounds possessing a range of ring substituents has been synthesized to probe the impact of structure on inhibitory mechanisms. Four active compounds were identified using HIV drug susceptibility assays. Three of the inhibitors possessing either no substituents or electron-withdrawing substituents on the aromatic rings led to high levels of cytotoxicity and antiviral activity. Intrigued by the potential implications of electronic effects on activity, we probed whether the active compounds could be nonspecifically reacting via 1,4-addition. To investigate this hypothesis, the compounds were incubated with glutathione and upon LUMS analysis, molecular ion peaks corresponding to both mono and double addition adducts were identified. Second, we synthesized analogs lacking the ability to participate in 1,4-addition and tested them for antiviral activity and cytotoxicity, and found the compounds inactive for both activities. Taken together, the studies reported herein suggest that compounds lacking electron-donating substituents on the aromatic ring are promiscuous acceptors of biological nucleophiles, whereas compounds possessing electron-donating substituents seem to resist addition or at least be more selective and significantly less toxic. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1127 / 1137
页数:11
相关论文
共 50 条
  • [1] BIOLOGICAL-ACTIVITY AND TOPOLOGICAL PROPERTIES OF HIV-1 INHIBITORS
    ROMANOWSKA, K
    POLISH JOURNAL OF CHEMISTRY, 1993, 67 (04) : 755 - 757
  • [2] Calculation of substituent effects on pKa values for pyrone and dihydropyrone inhibitors of HIV-1 protease
    Topol, IA
    Burt, SK
    Rashin, AA
    Erickson, JW
    JOURNAL OF PHYSICAL CHEMISTRY A, 2000, 104 (04): : 866 - 872
  • [3] Antimalarial activity of HIV-1 protease inhibitors
    Parikh, Sunil
    Gut, Jiri
    Istvan, Eva
    Sijwali, Puran
    Liu, Jun
    Havlir, Diane V.
    Goldberg, Daniel E.
    Rosenthal, Philip J.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2005, 73 (06): : 110 - 111
  • [4] HIV-1 integrase strand transfer inhibitors (INSTIs): Design, synthesis and biological activity
    Ferro, S.
    Barreca, M. L.
    De Luca, L.
    Rao, A.
    Monforte, A. M.
    Michiels, M.
    Witvrouw, M.
    Debyser, Z.
    Chimirri, A.
    PROCEEDINGS OF THE 5TH JOINT MEETING ON MEDICINAL CHEMISTRY, 2007, : 11 - 15
  • [5] Design, Synthesis and Biological Activity of Aromatic Diketone Derivatives as HIV-1 Integrase Inhibitors
    Hu, Liming
    Li, Zhipeng
    Wang, Zhanyang
    Liu, Gengxin
    He, Xianzhuo
    Wang, Xiaoli
    Zeng, Chengchu
    MEDICINAL CHEMISTRY, 2015, 11 (02) : 180 - 187
  • [6] Current developments in the synthesis and biological activity of HIV-1 double-drug inhibitors
    Muhanji, Clare I.
    Hunter, Roger
    CURRENT MEDICINAL CHEMISTRY, 2007, 14 (11) : 1207 - 1220
  • [7] Novel dimeric aryldiketo containing inhibitors of HIV-1 integrase: Effects of the phenyl substituent and the linker orientation
    Zeng, Li-Fan
    Jiang, Xiao-Hua
    Sanchez, Tino
    Zhang, Hu-Shan
    Dayam, Raveendra
    Neamati, Nouri
    Long, Ya-Qiu
    BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (16) : 7777 - 7787
  • [8] Effects of HIV-1 entry inhibitors in combination
    Tremblay, C
    CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (15) : 1861 - 1865
  • [9] BIOLOGICAL ACTIVITY AND SUBSTITUENT EFFECTS
    OSULLIVAN, DG
    SADLER, PW
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1957, 66 (01) : 243 - 245
  • [10] HIV-1 protease inhibitors with picomolar potency against PI-resistant HIV-1 by modification of the P1′ substituent
    Duffy, JL
    Kirk, BA
    Kevin, NJ
    Chapman, KT
    Schleif, WA
    Olsen, DB
    Stahlhut, M
    Rutkowski, CA
    Kuo, LC
    Jin, LX
    Lin, JH
    Emini, EA
    Tata, JR
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (19) : 3323 - 3326